The University Of Texas Health Science Center At Houston

The University Of Texas Health Science Center At Houston (UT Health Houston), operating through its University Of Texas - Bursars Office Division, is a state-controlled academic health institution and child entity of the University of Texas System that serves federal agencies as a prime contractor (78% of recent awards) and subcontractor on medical education, clinical research, and health professions training programs. The institution competes in full-and-open contract and grant categories with no set-aside designations; all named recent awards carry no set-aside language.

UT Health Houston's federal customer base concentrates heavily on Navy medical education. The Department of the Navy Bureau of Medicine and Surgery accounts for 18 awards and $2.2 million in combined potential value — 70% of recent activity by count and 93% of combined potential value across the top five funders. The remaining customer tier includes the Department of the Army (7 awards), the Department of the Navy (3 awards, $265 thousand combined potential value), the National Institute of Dental and Craniofacial Research (2 awards), and the Department of Veterans Affairs (1 award, $34 thousand combined potential value). The concentration is extreme: Navy tuition and fees awards dominate by volume and dollars, reflecting a narrow capability focus.

UT Health Houston's prime contract work consists almost entirely of delivery orders for tuition and fees supporting Navy medical personnel training through a Basic Ordering Agreement (BOA N0018919GZ078) established in 2019. Twenty task orders under this BOA carry $2.4 million in combined potential value, ranging from $3,999 to $256,667 per order and spanning fiscal-year training cycles from August through July or May through May. Representative awards include a $226,790 delivery order for the August 2025–July 2026 annual term, a $175,205 order for the prior fiscal year, and a $80,485 order for spring 2025 training. These awards are firm fixed price with no subcontractor involvement. The institution also holds an Indefinite Delivery Contract with the Department of the Army (DADA1097D0001) generating 5 task orders, though the source does not specify scope or values. One award (September 2024) from the National Center for Chronic Disease Prevention and Health Promotion supports statewide perinatal quality collaboratives.

In its subcontractor role, UT Health Houston performs clinical research site management and specialized biomedical expertise. The institution oversees syphilis specimen collection, enrollment, and follow-up at a clinical research site as a sub to the University of North Carolina at Chapel Hill (January 2023). UT Health Houston also provides biomarker analysis, clinical interpretation, and maternal-pelvis modeling expertise to Temple University on a pediatric obstetrics research grant (April 2024), and participates in antimicrobial protein-scaffold research with Texas A&M University System Health Science Center (two sub-awards: November 2023 and August 2024). Additional sub-grant roles include pediatric adverse-event risk reduction research with the University of Pittsburgh (December 2025), reading intervention development with the University of Virginia's Children's Learning Institute (December 2023), and public health analytics supporting COVID-19 disparities research with Harris County (October 2021).

Activity has remained modest and flat — three awards in 2022, five in 2023, seven in 2024, five in 2025, and one in early 2026 — with combined potential value of $2.7 million across 46 total awards (prime and sub). Only one award carries an ultimate completion date within the next twenty-four months ($227 thousand combined potential value). The institution's federal footprint is tightly bound to Navy medical education provisioning through a single BOA, with peripheral clinical research participation through academic partnerships.